ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Diagnostics and tools companies at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
76 diagnostics and tools companies are at ESMO 2026 — 35 presentations on the program and 62 with a booth in the exhibit hall. Most represented: Medical Genetics Institute (5 on the program), Larvol (3 on the program), Chronomics (2 on the program). 64 of them have their own page in this guide. As of Nov 2, 2026.
Tumour type
Top represented
Showing 1–12 of 76 organizations
| Organization | ESMO 2026 Attendance |
|---|---|
MG Medical Genetics Institute Ho Chi Minh City, Vietnam | |
Genetics institute in Ho Chi Minh City, Vietnam, doing hereditary cancer testing and blood-based cancer detection research. | Satellite Fri Oct 23 10:03–10:15 Satellite Fri Oct 23 10:39–10:47 3D Patient-Derived Organoids in Precision Medicine: From Bench to Bedside Biomarkers & precision oncology Poster Fri Oct 23 15:15–16:00 Poster Fri Oct 23 15:15–16:00 Implementing comprehensive genomic profiling in Southeast Asia: Real-World feasibility and performance across multiple cancer types Gastrointestinal cancersBiomarkers & precision oncology Poster Fri Oct 23 15:15–16:00 Real-world performance of dual tissue and liquid biopsy profiling for managing gastrointestinal and hepatobiliary cancers in Southeast Asia Gastrointestinal cancersBiomarkers & precision oncology |
Larvol San Francisco, CA | |
Company providing artificial intelligence and data tools for oncology research and clinical decision support. | Poster Fri Oct 23 13:00–15:00 Treatment decision-making in multiple myeloma: Comparison of AI models with expert myeloma oncologists Haematological malignancies Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 |
C Chronomics London, United Kingdom | |
Company developing data-driven health risk assessment and prediction tools. | Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 15:15–16:00 Poster Sun Oct 25 12:00–12:45 |
Clinical laboratory company offering diagnostic testing, including oncology tests, and central-laboratory services for drug development. | Booth Exhibiting at Booth 1088 Poster Mon Oct 26 12:00–12:45 Histotype, mutational, and immune gene expression correlates of PD-L1 immunohistochemistry in real-world cohort of ovarian cancer cases Gynaecological cancersBiomarkers & precision oncology Poster Mon Oct 26 12:00–12:45 Validation of a multiparametric flow cytometry panel for quantifying CD20 expression in CLL whole blood during mosunetuzumab therapy Haematological malignanciesBiomarkers & precision oncology |
Abbott Abbott Park, IL | |
Global healthcare company making diagnostics, medical devices and nutrition products; now owns Exact Sciences' cancer testing business. | Booth Exhibiting at Booth 8071 · Exact Sciences Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Satellite Mon Oct 26 13:00–14:30 |
Chinese precision oncology company offering cancer genomic profiling and early detection tests. | Booth Exhibiting at Booth 8029 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Analytical validation of onco-transcan for whole-transcriptome RNA expression profiling and PAM50 subtyping in solid tumors Breast cancerBiomarkers & precision oncology Poster Fri Oct 23 13:00–15:00 Clinical utility of FusionCapture RNA NGS for resolving ALK fusion variants to inform targeted therapy in lung cancer Lung & thoracic cancersBiomarkers & precision oncology |
Dxcover Glasgow, United Kingdom | |
Develops liquid biopsy tests for early cancer detection. | Poster Sun Oct 25 12:00–12:45 The evaluation of blood- and stool-based tests for the earlier detection of colorectal cancer Gastrointestinal cancers Poster Mon Oct 26 12:00–12:45 Evaluation of a multiomic liquid biopsy platform for high-sensitivity detection of ovarian cancer Gynaecological cancersBiomarkers & precision oncology |
SX Shanghai Xiaohe Medical Laboratory Shanghai, China | |
Medical laboratory company in Shanghai, China. | Poster Mon Oct 26 12:00–12:45 A cell-free DNA methylation-based liquid biopsy for multi-cancer early detection (MCED) demonstrates excellent performance in neuroendocrine carcinomas (NECs) Sarcoma, CNS, head & neck and rare cancersBiomarkers & precision oncology Poster Mon Oct 26 12:00–12:45 Cell-free DNA (cfDNA) methylation-based liquid biopsy to stratifying aggressiveness of lung adenocarcinoma Lung & thoracic cancersBiomarkers & precision oncology |
Amoy Diagnostics (AmoyDx) Xiamen, China | |
Chinese maker of PCR and NGS companion diagnostic kits for cancer gene alterations. | Booth Exhibiting at Booth 8059 Poster Fri Oct 23 13:00–15:00 |
Indian molecular diagnostics company making PCR and NGS test kits and instruments. | Booth Exhibiting at Booth 1060 Poster Fri Oct 23 13:00–15:00 Standardized CML detection and MRD monitoring using a lyophilized cold chain–free BCR-ABL RT-PCR assay on OnePCR and Rapi-Q platforms Haematological malignanciesBiomarkers & precision oncology |
Genetic testing company whose Signatera tumour-informed ctDNA test tracks molecular residual disease and treatment response. | Booth Exhibiting at Booth 1015 Poster Fri Oct 23 15:15–16:00 Plasma whole-exome sequencing (pWES) reveals somatic landscape and clonal dynamics in metastatic urothelial carcinoma Genitourinary cancersBiomarkers & precision oncology |
NA | |
AI company building research agents and a biomedical knowledge base for drug development teams. | Booth Exhibiting at Booth 1090 |
Find buyers from diagnostics and tools companies
Tell us what you sell and we’ll find the people at these diagnostics and tools companies most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse ESMO 2026 by
Organization type
Tumour type
Exhibit hall
Everyone
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction